This workshop will help Nurse Practitioners communicate effectively in basic Spanish phrases. Participants will gain a primary understanding of the Spanish language, an overview of Spanish speaking cultures and an introduction to basic pronunciation, the alphabet, grammar, and vocabulary for conversational Spanish. Participants will be able to verbalize basic Spanish greetings, perform a basic health assessment, and speak in conversational medical phrases.
Objectives
Outline
Lecture 1 - Fundamentals of Spanish
1. Introductions and basic greetings
2. Learning Spanish
1) Demographics of our nation
2). Competencies of communication, safety and quality care
Stories: ducharme, senor confused in 4-point restraints
3). Fun and useful 2nd language
3. Components of learning a foreign language
a. Guidelines to learning a 2nd language: learn parts of speech/language, listen/train your ear, practice and speak
b. Parts of language: vocab, grammar, pronunciation, comprehension, fluency
c. Simple steps to learn a foreign language
4. Cultural Considerations
a. Gender/machismo
b. Time, space
c. Attitudes of health and illness
d. Religion and values, demonstration of affection, family
5. Vocab: alphabet, vowels, & cognates
a. Alphabet/vowels
b. Cognates, near cognates, cognate verbs
6. Grammar: question words
a. parts of speech
b. key phrases
c. gender nouns
d. articles
7. Dialog: How to Understand a Spanish Speaking Patient
8. Easy translation
a. Guidelines to the Touch and Talk technique for health care providers
b. How to Initiate a One-Word Response
9. Dicho: El tiempo lo cura todo. Time heals all wounds.
10. Spotlight- North America & Mexico
Lecture 2- The health care interview
1. Greeting phrases, using a dictionary.
2. Vocab: time, hour, numbers
3. Grammar: nouns and plurals, idioms
4. Question words for the healthcare interview, professions
5. Practice scenario: common health conditions and illnesses
6. Dicho: El remedio puede ser peor que la enfermedad.
Sometimes the remedy is worse than the disease.
7. Culture-Spain
Lecture 3- Assessing Patients
1. Greeting: Yo soy_______.
2. Vocab: parts of the body
3. Grammar: Pronouns, Verbs AR, ER and IR, expressing a negative
4. Dialog: Creating the either/or questioning approach
5. Scenario: Stimulating the yes/no answers, ER visit
6. Dicho: Hacer de tripas corazón.
What can't be cured must be endured.
7. Culture Focus: Belize, Guatemala, Honduras
Lecture 4
1. Greeting/question to partner “Que trabajo hace?”
2. Vocab: family
3. Grammar-Irregular verbs IR: Tener, querer, ir
4. Dialog practice: case senarios w/Garcia family
5. Practice scenario- Neurological system and Integumentary system
6. Saying/Dicho: El que algo quiere, algo le cuesta.
He that would have the fruit must climb the tree.
7. Cultural insight of a country-El Salvador, Dominican Republic, Nicaragua
Lecture 5
1. Greeting/question to partner “Quien es en su familia?”
2. Vocab: food, medications
3. Grammar- prefixes/suffixes, possessives, verbs Ser and Estar
4. Dialog practice: medications, remedies, typical medical scenarios
5. Practice scenario-Cardiovascular system and respiratory scenario
6. Saying/Dicho: Dime con quien andas, y te dire quien eres.
You can judge a man by the company he keeps.
7. Cultural insight of a country-Panama, Costa Rica, Colombia
Lecture 6
1. Greeting/question to partner “Que es su pasatiempo?”
2. Vocab- directions, medical tests, equipment and settings
3. Grammar- verb forms
4. Dialog practice: diagnostic tests
5. Practice scenario-GI, GU and MS vocabulary
6 Saying/Dicho: Persevera y triunfaras.
If at first you don't succeed, try, and then try again.
7. Cultural insight of a country-Chile, Uruguay, Paraguay Peru
Lecture 7
1. Greeting/question to partner “Que le gusta comer?”
2. Vocab- time, days of week, months of year, seasons
3. Grammar- prefixes, suffixes, adjectives,
4. Dialog: giving a diagnosis, medical equipment, specialists
5. Practice scenario-Reproductive system & mental health
6. Saying/Dicho: Paga lo que debes, sanaras del mal que tienes
Pay your debts and that will cure your disease.
7. Cultural insight of a country-Bolivia, Venezuela, Ecuador, Argentina
Lecture 8
1. Greeting/question to partner “Que le gusta hacer?”
2. Vocab- clothing & colors
3. Grammar: mock scenarios and patient referrals and discharge
4. Dialog- when to use a translator effectively
5. Practice scenario- mock scenarios
6. Dicho: Change can renew your energy.
7. Cultural insight of a country- Islands
8. How to advance your Spanish
Target Audience
Join Dr. Sanul Corrielus, a board-certified cardiologist, best-selling author in heart health and CEO of Corrielus Cardiology to address the greatest challenges to manage hypertension. The 2017 ACC/AHA Hypertension Guideline introduced key changes in blood pressure classification and management, lowering the threshold for diagnosing hypertension. Normal blood pressure is now defined as <120/80 mm Hg, while hypertension is classified into elevated (120-129/<80 mm Hg), stage 1 (130-139/80-89 mm Hg), and stage 2 (≥140/90 mm Hg). This has increased the prevalence of hypertension, encouraging earlier detection and intervention. Lifestyle changes are advised for stage 1, but pharmacological treatment is recommended for stage 2 or stage 1 with cardiovascular disease or a 10-year ASCVD risk ≥10%. The guideline sets a blood pressure goal of <130/80 mm Hg for most adults and focuses on specific populations. African Americans at higher risk for complications may require thiazide diuretics or calcium channel blockers. For those with diabetes, tight control of blood pressure is vital to prevent complications, with the same target of <130/80 mm Hg. Older adults should aim for the same goal but with consideration of overall health. Resistant hypertension, where blood pressure remains uncontrolled with three agents, requires further evaluation. Adherence to treatment and lifestyle changes is critical for achieving and maintaining blood pressure control and reducing cardiovascular risks.
Objectives
Outline
Target Audience
Diabetes management is evolving rapidly, with new medications, updated guidelines, and innovative approaches to optimizing glycemic control while minimizing complications. This one-hour session will explore the latest updates in pharmacologic treatment for diabetes, providing a comprehensive review of the nine major classes of diabetes medications, their mechanisms of action, and key clinical considerations.
Through an engaging lecture and interactive case study, gain practical insights into selecting the most effective treatments based on individual patient needs. Whether managing type 1 or type 2 diabetes, take away the knowledge to implement evidence-based strategies for improved patient outcomes. Stay ahead of the latest advancements and refine your approach to diabetes pharmacology!
Objectives
Outline
Diabetes Medication Classes
Target Audience
Please join Dr. Peter Burch, a double certified clinical gastroenterologist with over 30 years of specialty experience, to explore GERD in a practical, case based, and interaction session. He will provide the highlights on alarm signs with GERD, medical mimickers of GERD, making the correct diagnosis of GERD, clinical differences between PPIs, and discussion on Vonoprazan as a PPI alternative.
At the conclusion of the training, you will have the necessary clinical updates and tools to confidently manage patient with GERD, dyspepsia, and Barrett’s esophagus.
Objectives
Outline
GERD
Target Audience
With pronounced longevity and improved survival after myocardial infarcts, we see more patients than ever with heart failure. Patients with chronic low cardiac outputs can be a challenge to manage, especially as new medications and management tools become available every year. During this session, Cyndi Zarbano, MSN-Ed, CCRN, CMSRN, LNC, will explore emergency interventions for acute decompensation, causes, and new management guidelines to treat and slow the progression of the heart failure disease process. Discover best practice strategies to prevent and manage heart failure exacerbations!
Objectives
Outline
Metabolic Syndrome
Target Audience
Culture plays a significant role in how individuals view themselves and their role in the family and the world around them. Therefore, patients’ approach to their healthcare needs, including illness and death, is directly impacted by cultural factors. When caring for the aging populations, you should personalize care with the patient’s cultural factors in mind. Latasha Ellis, PhD, LCSW, LISW-CP, OSW-C, will provide important factors and practices to consider when delivering culturally responsive healthcare services to the elderly population.
Objectives
Outline
Cultural Competence and Cultural Humility
Target Audience
Dyslipidemia management requires a multifaceted approach that includes both lifestyle modifications and pharmacotherapy. The primary goal of treatment is to reduce LDL-C levels to lower cardiovascular (CV) risk. Additionally, some patients may require other therapies to address residual CV risk associated with elevated triglycerides or elevated lipoprotein(a) [Lp(a)].
The 2018 AHA/ACC/Multisociety cholesterol guideline emphasized the importance of lowering LDL-C as the primary treatment target. This guideline focuses on populations where statin therapy has been proven to lower both LDL-C and CV event risk, known as the four statin benefit groups. In 2022, the ACC published an Expert Consensus Decision Pathway for nonstatin therapy, recommending specific LDL-C thresholds for all four statin benefit groups, rather than just two as per the 2018 guideline. While statin therapy is effective in reducing CV risk and LDL-C levels, some patients may require additional nonstatin therapies to achieve optimal LDL-C reduction. Several nonstatin therapies, including ezetimibe, bempedoic acid, PCSK9 monoclonal antibodies, and inclisiran, are available and effective in further lowering LDL-C. This program will review these LDL-C lowering therapies and their optimal use to improve patient outcomes.
Even when LDL-C is reduced to recommended levels, patients with elevated triglycerides or Lp(a) remain at increased risk for CV events. Clinicians should be aware of the evidence linking elevated triglycerides and Lp(a) with CV events, as well as the latest innovations and outcomes data related to current and emerging drug therapies for these conditions. This session will review outcomes data on the use of omega-3 fatty acids in patients with elevated triglycerides. Additionally, it will cover two medications in phase III trials, pelacarsen and olpasiran, which lower Lp(a) in conjunction with statin therapy.
Objectives
Outline
LDL-C Lowering
Target Audience
Being a Healer is an informative session on the holistic nature of care, with a description of effective practices to promote healing as a provider. The focus of the session provides practical and affirming tips for providers, as it relates to the clinician’s role in the healing process.
Objectives
Outline
Define Healing
Target Audience